Log in to save to my catalogue

Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish compo...

Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish compo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2579207160

Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer

About this item

Full title

Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer

Publisher

Cham: Springer Science + Business Media

Journal title

Cancer causes & control, 2021-11, Vol.32 (11), p.1299-1313

Language

English

Formats

Publication information

Publisher

Cham: Springer Science + Business Media

More information

Scope and Contents

Contents

Purpose
Screening for prostate cancer may have limited impact on decreasing prostate cancer-related mortality. A major disadvantage is overdiagnosis, whereby lesions are identified that would not have become evident during the man’s lifetime if screening had not taken place. The present study aims to estimate the rate of overdiagnosis using Finn...

Alternative Titles

Full title

Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2579207160

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2579207160

Other Identifiers

ISSN

0957-5243

E-ISSN

1573-7225

DOI

10.1007/s10552-021-01480-8

How to access this item